The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
and so as I said this has not been solved completely at this point there have been other genetic therapies other diseases not just liver diseases but where there have been similar responses and I think one of the things that we've learned from this is we have to be very careful with people with underlying liver disease when it comes to this because the a fragile liver can get tipped over especially with adob us
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.